Skip to content

Attachment and Biobehavioral Catch-up and Depression Treatment

Efficacy of an Integrated Intervention to Treat Maternal Depression and Children's Behavior Problems: A Transactional Perspective

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05096611
Acronym
ABC+D
Enrollment
76
Registered
2021-10-27
Start date
2022-03-01
Completion date
2024-10-30
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Behavior Problem, Maternal Depression

Brief summary

Maternal depression influences the development of children's behavior problems and vice versa; however most interventions singularly address maternal depression or children's behavior problems rather than both. This project assesses the efficacy of an intervention that treats both mothers and children in an integrated manner. Effects are expected to disrupt the reciprocal relations that perpetuate maternal and child mental health problems over time.

Detailed description

The proposed project is a pilot randomized controlled trial to evaluate the effectiveness of an integrated intervention that dually treats maternal depressive symptoms and offspring behavior problems. Families (n = 40 mothers and their 2-to-4 year-old children) will be randomized to receive 10 sessions of ABC or 10 sessions of ABC+D in their home. ABC+D is an expanded version of ABC that additionally treats maternal depressive symptoms using Mothers and Babies adapted for mothers of toddlers. The specific aims of this proposed project are: Aim 1. Collect preliminary data on the feasibility and acceptability of ABC+D in preparation for a small pilot randomized controlled trial (RCT). Aim 2. Conduct a small pilot RCT to examine the effectiveness of ABC and ABC+D Aim 3: Assess the overall acceptability (mother- and provider-rated), appropriateness (mother- and provider-rated), and feasibility (provider-rated) of ABC+D. Mothers will also rate their satisfaction with each session and the degree to which it was helpful, interesting, and comprehensible.

Interventions

BEHAVIORALAttachment and Biobehavioral Catch up

ABC is delivered by a trained parent coach. The parent coach provides information about parenting and child development. The focus is on providing support for parents of young children and improving the parent-child relationship.

BEHAVIORALAttachment and Biobehavioral Catch up Plus Depression Treatment

ABC+D offers the same 10-sessions of parenting support that is provided by ABC and additionally provides weekly short videos that help mothers develop skills for coping with stress and regulating mood.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
2 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Mothers 18 years of age or older with heightened depressive symptoms as determined by a score of 5 or higher on the Patient Health Questionnaire-9 (PHQ-9) 2. Biological children (of mothers described above) between 2 and 4 years old with heightened behavior problems as determined by a score of at least 3 in at least 1 domain of functioning on the Impairment Rating Scales 3. English- or Spanish-speaking

Exclusion criteria

1. Self-reported history of psychosis or active suicidality as defined by self-report of a specific suicide plan or recent attempt 2. Child diagnosis of autism

Design outcomes

Primary

MeasureTime frameDescription
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Depression ScoreBaseline to post-intervention. This is approximately 10 weeks.Scores range from 34.5 to 82.3 with higher values indicating more severe symptoms
Change in Early Childhood Screening Assessment (ECSA) ScoreBaseline to post-intervention. This is approximately 10 weeks.Scores range from 0 to 80 with higher values indicating more severe symptoms

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDanielle Roubinov, PhD

University of California, San Francisco

Participant flow

Recruitment details

Participants were recruited between March 2022 and August 2024. Recruitment occurred online.

Pre-assignment details

The number of enrolled participants reflect the total number of mothers and children. There were 38 dyads enrolled in the study reflecting 38 mothers and 38 offspring (76 total participants).

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
16 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
38 Participants
Age, Continuous
Child age in years
3.38 Years
STANDARD_DEVIATION 0.74
Age, Continuous
Mother age in years
33.79 Years
STANDARD_DEVIATION 6.27
Ethnicity (NIH/OMB)
Child ethnicity
Hispanic or Latino
10 Participants
Ethnicity (NIH/OMB)
Child ethnicity
Not Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Child ethnicity
Unknown or Not Reported
0 Participants
Ethnicity (NIH/OMB)
Mother ethnicity
Hispanic or Latino
14 Participants
Ethnicity (NIH/OMB)
Mother ethnicity
Not Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Mother ethnicity
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
Child race
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Child race
Asian
1 Participants
Race (NIH/OMB)
Child race
Black or African American
2 Participants
Race (NIH/OMB)
Child race
More than one race
5 Participants
Race (NIH/OMB)
Child race
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Child race
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
Child race
White
10 Participants
Race (NIH/OMB)
Mother race
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Mother race
Asian
5 Participants
Race (NIH/OMB)
Mother race
Black or African American
3 Participants
Race (NIH/OMB)
Mother race
More than one race
3 Participants
Race (NIH/OMB)
Mother race
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Mother race
Unknown or Not Reported
12 Participants
Race (NIH/OMB)
Mother race
White
12 Participants
Region of Enrollment
United States
38 participants
Sex: Female, Male
Child biological sex
Female
13 Participants
Sex: Female, Male
Child biological sex
Male
9 Participants
Sex: Female, Male
Mother biological sex
Female
16 Participants
Sex: Female, Male
Mother biological sex
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 44
other
Total, other adverse events
0 / 320 / 44
serious
Total, serious adverse events
0 / 320 / 44

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026